These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1669136)

  • 1. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical plasma components in patients with occlusive arteriosclerosis of the lower limbs].
    Turczyński B; Sroczyński J; Antoszewski Z; Matyszczyk B; Krupa G; Grzegorczyn S
    Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):700-3. PubMed ID: 1669136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical components in patients with diabetes type II and ischemia of the lower extremities].
    Turczyński B; Sroczyński J; Antoszewski Z; Matyszczyk B; Krupa G; Młynarski J; Strugala M
    Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):708-10. PubMed ID: 1669138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood and plasma viscosity and the distance of intermittent claudication in patients with type II diabetes and thrombophlebitis].
    Turczyński B; Sroczyński J; Matyszczyk B; Szczesny S; Strugala M
    Wiad Lek; 1990 Jun; 43(11):483-8. PubMed ID: 2219912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood and plasma viscosity versus claudication distance in patients with obliterative atherosclerosis of the lower limbs].
    Turczyński B; Sroczyński J; Matyszczyk B; Szczesny S
    Pol Arch Med Wewn; 1991 Jan; 85(1):41-9. PubMed ID: 2038575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemorheologic changes in patients with obliterative arteriopathy of the leg before and after muscle exercise tests].
    Bianco S; Todini AR; Fabiani F; Bartolo M
    J Mal Vasc; 1990; 15(3):291-5. PubMed ID: 2212878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical assessment of treatment results for atherosclerotic ischemia of the lower extremities with intraarterial ozone injections].
    Sroczyński J; Antoszewski Z; Matyszczyk B; Krupa G; Rudzki H; Zbrońska H; Skowron J
    Pol Tyg Lek; 1992 Oct 19-26; 47(42-43):964-6. PubMed ID: 1300589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemorheological disorders in patients with critical ischemia of the lower limbs of atherosclerotic genesis].
    Losev RZ; Zakharova NB; Burov IuA; Shesterikov IN
    Vestn Khir Im I I Grek; 2001; 160(3):52-5. PubMed ID: 11517791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kallikrein in the treatment of patients with obliterative atherosclerosis of the lower limbs and its mechanism of action].
    Kostka-Trabka E; Grodzińska L; Bieroń K; Basista M; Sławiński M; Kedzior A; Ochmański W
    Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):713-6. PubMed ID: 1669140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood viscosity and hematocrit indices in arteriosclerosis].
    Kazakov IuM
    Vrach Delo; 1981 Feb; (2):27-8. PubMed ID: 7222603
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the behavior of lipidemia, blood viscosity and arterial flow of the limbs after oral lipid loading. Observations in subjects with peripheral obliterating arteriopathies].
    Bartoli V; Dorigo B; Ponzeveroni A; Barletta O
    Mal Cardiovasc; 1969; 10(4):651-62. PubMed ID: 5405783
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of oral trapidil therapy on clinical and hemorheological parameters in arteriosclerosis obliterans in comparison to pentoxifylline--a pilot study].
    Regenthal R; Voigt H; Reuter W; Preiss R
    Z Gesamte Inn Med; 1991 Apr; 46(6):185-90. PubMed ID: 2063598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of nitrendipine in treating patients with obliterative atherosclerosis of arteries in the lower extremities].
    Grodzińska L; Kostka-Trabka E; Basista M; Bieroń K; Sławiński M; Telesz E
    Pol Tyg Lek; 1991 Aug 5-19; 46(32-34):598-600. PubMed ID: 1669121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease.
    Poredos P; Zizek B
    Angiology; 1996 Mar; 47(3):253-9. PubMed ID: 8638868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood and plasma viscosity after acipimox treatment in hypertriglyceridemic patients.
    Montefusco S; Iannaci G; Gnasso A; Cortese C; Lamenza F; Postiglione A
    Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):492-4. PubMed ID: 3235215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of effect of fatty meals on blood viscosity.
    Begg TB; Hearns JB
    Clin Sci; 1967 Jun; 32(3):551-7. PubMed ID: 6028132
    [No Abstract]   [Full Text] [Related]  

  • 16. [The efficacy of ticlid in treating intermittent claudication in atherosclerotic stenosis of the arteries of the lower extremities].
    Kirichenko AA; Prekina VI; Repinskaia NP; Novichkova IuN; Ter-Gevondian NM; Vinogradova IV
    Ter Arkh; 1994; 66(12):23-6. PubMed ID: 7900036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacotherapeutical action on arteriosclerotic vascular diseases with benzarone (author's transl)].
    Mörl H; Diehm C; Zimmermann R; Schöffel G; Walter E
    MMW Munch Med Wochenschr; 1980 Feb; 122(8):277-80. PubMed ID: 6767967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic defibrinogenation by ancrod: effect on limb blood flow in peripheral vascular disease.
    Wiles PG; Nelson SR; Hampton KK; Casali B; Boothby M; Prentice CR
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):385-8. PubMed ID: 2133215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperbaric oxygen, oxygen-ozone therapy, and rheologic parameters of blood in patients with peripheral occlusive arterial disease.
    Verrazzo G; Coppola L; Luongo C; Sammartino A; Giunta R; Grassia A; Ragone R; Tirelli A
    Undersea Hyperb Med; 1995 Mar; 22(1):17-22. PubMed ID: 7742706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intermittent claudication treated with pentoxifylline. A controlled trial].
    Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
    Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.